Showing 49 to 60 of 69 results
Common Drugs May Reduce Dementia Risk: Large-Scale Study
A study of over 130 million people found that common drugs like ibuprofen and antibiotics may reduce the risk of dementia, supporting the theory that infections might trigger some forms of the disease; however, experts say more research is needed.
Common Drugs May Reduce Dementia Risk: Large-Scale Study
A study of over 130 million people found that common drugs like ibuprofen and antibiotics may reduce the risk of dementia, supporting the theory that infections might trigger some forms of the disease; however, experts say more research is needed.
Progress
40% Bias Score
Pauline Quirke Steps Back From Acting Due To Dementia
Birds Of A Feather actress Pauline Quirke, 65, is stepping back from acting due to young-onset dementia diagnosed in 2021; early symptoms, like shortened attention spans and depression-like states, are often missed, highlighting the need for early detection and preventative measures, especially give...
Pauline Quirke Steps Back From Acting Due To Dementia
Birds Of A Feather actress Pauline Quirke, 65, is stepping back from acting due to young-onset dementia diagnosed in 2021; early symptoms, like shortened attention spans and depression-like states, are often missed, highlighting the need for early detection and preventative measures, especially give...
Progress
32% Bias Score
Wall Street Surges on Positive Inflation Data and Strong Bank Earnings
Wednesday's Wall Street surge stemmed from positive inflation data—the consumer price index (CPI) excluding food and energy coming in below expectations—and strong bank earnings, increasing the odds of Federal Reserve interest rate cuts and boosting investor confidence.
Wall Street Surges on Positive Inflation Data and Strong Bank Earnings
Wednesday's Wall Street surge stemmed from positive inflation data—the consumer price index (CPI) excluding food and energy coming in below expectations—and strong bank earnings, increasing the odds of Federal Reserve interest rate cuts and boosting investor confidence.
Progress
56% Bias Score
Dementia Risk in US to Double by 2060: Study
New research shows 42% of Americans over 55 will develop dementia, with annual diagnoses projected to double by 2060 due to the aging population and racial disparities, highlighting the urgent need for preventative policies.
Dementia Risk in US to Double by 2060: Study
New research shows 42% of Americans over 55 will develop dementia, with annual diagnoses projected to double by 2060 due to the aging population and racial disparities, highlighting the urgent need for preventative policies.
Progress
24% Bias Score
Counterculture Pioneer Revolutionizes British Food
Jonathan Nunn Nicholas Saunders, a counterculture pioneer, fundamentally changed the way Britons eat through various schemes, leaving a lasting legacy on British food culture.
Counterculture Pioneer Revolutionizes British Food
Jonathan Nunn Nicholas Saunders, a counterculture pioneer, fundamentally changed the way Britons eat through various schemes, leaving a lasting legacy on British food culture.
Progress
8% Bias Score
Dementia Deaths Rise to Top Cause in the UK
Dementia was the leading cause of death in the UK in 2023, killing over 75,000 people, a rise from 74,261 in 2022 and 69,178 in 2021; experts warn of a worsening crisis unless the government acts to improve services and access to new treatments.
Dementia Deaths Rise to Top Cause in the UK
Dementia was the leading cause of death in the UK in 2023, killing over 75,000 people, a rise from 74,261 in 2022 and 69,178 in 2021; experts warn of a worsening crisis unless the government acts to improve services and access to new treatments.
Progress
60% Bias Score
Study Links Common Medications to Increased or Decreased Dementia Risk
Analysis of 14 studies involving over 130 million individuals reveals that certain medications (antipsychotics, some blood pressure and diabetes drugs, antidepressants, vitamins/supplements) may increase dementia risk, while others (vaccines, anti-inflammatories, antibiotics) show a potential risk r...
Study Links Common Medications to Increased or Decreased Dementia Risk
Analysis of 14 studies involving over 130 million individuals reveals that certain medications (antipsychotics, some blood pressure and diabetes drugs, antidepressants, vitamins/supplements) may increase dementia risk, while others (vaccines, anti-inflammatories, antibiotics) show a potential risk r...
Progress
40% Bias Score
Xenon Gas Shows Promise as Alzheimer's Treatment in Mouse Study
A US study found inhaling xenon gas reduced brain inflammation and improved cognitive function in mice with Alzheimer's, leading to plans for a human trial; xenon's ability to cross the blood-brain barrier is key.
Xenon Gas Shows Promise as Alzheimer's Treatment in Mouse Study
A US study found inhaling xenon gas reduced brain inflammation and improved cognitive function in mice with Alzheimer's, leading to plans for a human trial; xenon's ability to cross the blood-brain barrier is key.
Progress
48% Bias Score
U.S. Dementia Cases Projected to Double by 2060
A new study projects a doubling of new U.S. dementia cases by 2060, reaching approximately 1 million annually, primarily due to population aging; the lifetime risk after age 55 is 42%, with disparities across demographics highlighting the urgent need for health equity policies.
U.S. Dementia Cases Projected to Double by 2060
A new study projects a doubling of new U.S. dementia cases by 2060, reaching approximately 1 million annually, primarily due to population aging; the lifetime risk after age 55 is 42%, with disparities across demographics highlighting the urgent need for health equity policies.
Progress
44% Bias Score
Brain-on-a-Chip Improves Alzheimer's Drug Development
The International Iberian Nanotechnology Laboratory (INL) developed a brain-on-a-chip microdevice using microfluidics and a bio-membrane to simulate the blood-brain barrier, enabling more efficient testing of Alzheimer's drugs and reducing reliance on animal testing, potentially accelerating new tre...
Brain-on-a-Chip Improves Alzheimer's Drug Development
The International Iberian Nanotechnology Laboratory (INL) developed a brain-on-a-chip microdevice using microfluidics and a bio-membrane to simulate the blood-brain barrier, enabling more efficient testing of Alzheimer's drugs and reducing reliance on animal testing, potentially accelerating new tre...
Progress
32% Bias Score
New Focused Ultrasound Device Promises Revolution in Brain Cancer and Alzheimer's Treatment
Sunnybrook Research Institute developed a new helmet-like device using focused ultrasound to treat brain conditions like brain cancer and Alzheimer's, eliminating the need for MRI machines, significantly expanding accessibility and reducing costs; human clinical trials are planned for 2025.
New Focused Ultrasound Device Promises Revolution in Brain Cancer and Alzheimer's Treatment
Sunnybrook Research Institute developed a new helmet-like device using focused ultrasound to treat brain conditions like brain cancer and Alzheimer's, eliminating the need for MRI machines, significantly expanding accessibility and reducing costs; human clinical trials are planned for 2025.
Progress
52% Bias Score
Low-Level Glyphosate Exposure Linked to Persistent Alzheimer's-Like Brain Changes in Mice
A study on mice revealed that low-level exposure to glyphosate, a common herbicide found in various foods, caused persistent Alzheimer's-like brain changes, raising concerns about its long-term health effects and the need for further human research.
Low-Level Glyphosate Exposure Linked to Persistent Alzheimer's-Like Brain Changes in Mice
A study on mice revealed that low-level exposure to glyphosate, a common herbicide found in various foods, caused persistent Alzheimer's-like brain changes, raising concerns about its long-term health effects and the need for further human research.
Progress
48% Bias Score
Showing 49 to 60 of 69 results